has been acquired by

a portfolio company of

February 2026 – England & Company is pleased to announce that Nimble Co., LLC, dba Purview (“Purview”), a health technology company specializing in secure medical imaging, intelligent record access, and expert second opinion platforms, has been acquired by HealthMark Group (“HealthMark”). England & Company served as exclusive financial advisor to Purview in this transaction.

Purview’s platforms, Purview Image™ and Expert View™, enable secure, instant access to disparate medical data sources (including DICOM images, EHRs, lab results, and more), transforming raw data into contextualized, case-oriented insights. This supports critical applications, including remote second opinions, pre-surgical reviews, litigation support, veterinary imaging, and specialist consultations. Trusted by leading children’s hospitals and academic medical centers, Purview helps healthcare organizations overcome geographic barriers to care by enabling secure collaboration, virtual access to specialized expertise, and faster, more informed decision-making through medical records and imaging.

HealthMark, a portfolio company of TA Associates, is a leading provider of clinical information exchange solutions for healthcare providers across the country. HealthMark delivers secure, compliant, and technology-driven solutions to streamline the patient information journey. Its health data exchange solution helps thousands of hospitals and clinics transform administrative processes into seamless digital encounters. This acquisition enhances HealthMark’s offerings by adding Purview’s innovative SaaS capabilities, supporting efficient, compliant medical record exchange across stakeholders. The integration of Purview into HealthMark’s clinical data exchange solution will provide complete, timely, and secure access to medical imaging data across regions, institutions, and care settings.

Les Trachtman, CEO of Purview, noted that “the England team was instrumental in leading us through a competitive process that identified HealthMark as the optimal partner for Purview. Their insights were essential to organizing the sale process and getting us to the finish line.”

has acquired

October 2025 – Electro-Mechanical LLC, a leading manufacturer of medium voltage switchgear and electrical apparatus and a portfolio company of funds managed by Oaktree Capital Management, L.P., has acquired Powercon Corporation, a premium provider of custom-designed medium voltage switchgear, e-houses, and modular substation power systems. Founded in 1959, Powercon has over 65 years of experience delivering highly engineered, premium quality, and innovative power distribution and control solutions, backed by a commitment to exceptional customer service.

The acquisition further strengthens Electro-Mechanical’s capabilities in medium voltage switchgear and integrated systems for utility, data center, and critical infrastructure applications. Electro-Mechanical is committed to providing Powercon with investment, resources, and support to enhance capacity to serve customers and deliver long-term growth, while maintaining the company’s culture that has been central to its success.

“Our customers are facing increasingly complex power challenges each year,” said Howard Broadfoot, President of Electro-Mechanical, LLC. “Powercon’s robust product portfolio and deep engineering expertise provide practical, innovative solutions. Together, we can deliver a comprehensive suite of medium voltage switchgear and related solutions to utility and critical infrastructure customers across the country.”

England & Company served as a financial advisor to Electro-Mechanical, LLC in this transaction.

has agreed to be acquired by

October 2025 – England & Company is pleased to announce that it has served as the exclusive financial advisor to YData Labs, Inc. (“YData” or the “Company”) on its pending acquisition by KPMG US. This transaction deepens England’s Technology footprint advising companies across the Artificial Intelligence (“AI”) and broader IT infrastructure ecosystem.

YData was founded in 2019 to unlock the power of synthetic data to accelerate innovation, ensure privacy, and enable AI through improved quality data. What started as a vision to make data more accessible grew into a platform trusted by teams around the world.

With this acquisition, KPMG will strengthen its AI client offerings, harness synthetic data to enhance AI-enabled client delivery for Audit and Assurance, Tax and Advisory services, and establish a Synthetic Data Center of Excellence designed to accelerate innovation and safeguard client confidentiality.

Gonçalo Martins Ribeiro, Founder and CEO of YData, commented, “England was an exceptional partner throughout this process. Their deep understanding of the AI infrastructure ecosystem and connectivity into key stakeholders coupled with expert process guidance, was instrumental in allowing YData to position the Company to play a key role in how synthetic data will shape the future of AI.”

“In a rapidly evolving AI landscape, synthetic data is playing a key role in testing, training and deploying solutions while balancing privacy, compliance and time-to-value demands,” noted England Managing Director, Joel Strauch. “YData combines a leading-edge platform with deep technical expertise to build, test, and scale synthetic data to support AI. We’re honored to have had the opportunity to partner with the YData team and look forward to seeing their continued success as part of KPMG.”

has been acquired by

July 2025 – England & Company is pleased to announce that NIRx Medical Technologies, LLC (“NIRx”), a pioneer in functional Near-Infrared Spectroscopy (fNIRS) neuroimaging systems and the market leader in this rapidly growing market, has been acquired by Gilde Healthcare Partners BV (“Gilde”), a Netherlands-based healthcare investor specializing medtech, digital health, and therapeutics. NIRx’s systems enable non-invasive, radiation-free, real-time brain imaging for neuroscience research in both lab and natural settings. As part of a strategic combination, Gilde has also acquired Artinis Medical Systems B.V. (“Artinis”), a complementary fNIRS company. This combination creates a global leader in fNIRS and is the foundation for building a market leader in innovative neuroimaging and neuroscience research tools more broadly.

NIRx Group CEO, Richard Barbour, said: “The England team added significant value in negotiating this transaction and bringing it to a successful close. They also went above and beyond with additional financial advisory assistance.” Dr. Patrick Britz, CEO of NIRx GmbH added “It was really a pleasure working with the England team. Their support, attention to detail, diligence, and advice on the deal were instrumental in achieving this amazing result.”

NIRx provides cutting-edge solutions to researchers in human neuroscience to enhance the understanding of the human mind, health, and disease. Through its innovative and comfortable-wearing head gear, NIRx offers a host of integrated technology solutions that support a wide range of investigative aims – from exploring early language acquisition in infants to motor movements in the natural environment to BCI applications or new understandings involving coordinated actions between sensory systems, NIRS imaging solutions from NIRx constitute a comprehensive resource that meet the most demanding applications.

As established leaders in fNIRS, NIRx and Artinis will merge as a newly formed platform within Gilde for neuroimaging and corresponding research tools, all while driving innovation across multiple modalities. The goal of this new platform is to enhance the adoption of fNIRS in applied neuroscience by setting industry standards and making the technology more accessible to academic and institutional researchers globally.

“By bringing both companies together, we are creating a platform that will lead innovation and makes brain imaging tools more accessible to researchers globally,” said Boyd Rutten, Investment Director, Gilde Healthcare.

has agreed to acquire

January 2025 – England & Company is pleased to announce that its client, SGB-SMIT Group (“SGB-SMIT”), a leading independent transformer manufacturer that manufactures capital goods for power supply and is a global market leader with its products, has entered into an agreement to acquire Southwest Electric Co. (“Southwest Electric”), an electrical component manufacturer and service provider. The transaction is expected to close in the first quarter of 2025.

Founded in 1913, SGB-SMIT is headquartered in Regensburg, Germany, and operates 14 locations across eight countries. SGB-SMIT and its affiliate OTC Services in Louisville, Ohio, have served the U.S. market for decades with small, medium, and large power transformers and related services.

has been acquired by

December 2024 – England & Company is pleased to announce that it served as the exclusive financial advisor to Xtensible Solutions, LLC (“Xtensible”), a global leader in semantic-based integration and information data management solutions, in its sale to Surveying and Mapping, LLC (“SAM”), a Managed Geospatial Services Company , which focuses on utilities, transportation, and infrastructure clients.

Based in Orlando, Florida, Xtensible has established itself as a prominent leader in standards-based consulting for the utility sector for over two decades. The company is an innovative leader in semantic-based integration and information data management solutions for the utility industry worldwide. Semantic integration permits the sharing and interoperability of data and systems across different platforms, applications, and stakeholders so utilities can more easily apply advanced analytics, machine learning, and automation across their organizational data streams and operational footprint to improve decision-making.

The organization is widely recognized for its innovative Model-Driven Integration (MDi) and Model-Driven Data-Driven Integration (MD3i) software architectural frameworks. SAM is poised to leverage these cutting-edge solutions to enhance its clients’ value.